T1	PROC 185 192	tratado
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	CHEM 85 94	nivolumab
#2	AnnotatorNotes T2	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	CHEM 104 113	nivolumab
#3	AnnotatorNotes T3	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	PROC 117 128	monoterapia
#4	AnnotatorNotes T4	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T5	DISO 146 166	Melanoma metastásico
T6	PROC 229 272	Estudio fase 2/3, aleatorizado, doble ciego
T7	CHEM 314 323	nivolumab
#5	AnnotatorNotes T7	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T8	CHEM 333 342	nivolumab
#6	AnnotatorNotes T8	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T9	PROC 346 357	monoterapia
#7	AnnotatorNotes T9	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T10	DISO 375 395	Melanoma metastásico
T11	DISO 460 468	Melanoma
#8	AnnotatorNotes T11	C0025202; melanoma; Neoplastic Process
T12	DISO 504 524	Melanoma metastásico
T13	PROC 414 421	tratado
#9	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	PROC 792 824	tratamiento oncológico sistémico
T15	DISO 837 845	melanoma
#10	AnnotatorNotes T15	C0025202; melanoma; Neoplastic Process
T16	DISO 898 905	tumoral
#11	AnnotatorNotes T16	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T17	DISO 958 968	enfermedad
#12	AnnotatorNotes T17	C0012634; Disease; Disease or Syndrome
T18	PROC 974 999	análisis de biomarcadores
T19	DISO 1026 1047	Metástasis cerebrales
#13	AnnotatorNotes T19	C0220650; Metastatic malignant neoplasm to brain; Neoplastic Process | C0555278; Cerebral metastasis; Neoplastic Process
T20	DISO 1058 1083	metástasis leptomeníngeas
#14	AnnotatorNotes T20	C1704231; Metastatic Malignant Neoplasm to the Leptomeninges; Neoplastic Process
T21	DISO 1085 1100	Melanoma ocular
#15	AnnotatorNotes T21	C0558356; Malignant melanoma of eye; Neoplastic Process
T22	DISO 1121 1142	enfermedad autoinmune
#16	AnnotatorNotes T22	C0004364; Autoimmune Diseases; Disease or Syndrome
T23	PROC 543 550	tratado
#17	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	DISO 621 629	melanoma
#18	AnnotatorNotes T24	C0025202; melanoma; Neoplastic Process
T25	DISO 860 871	metastásico
#19	AnnotatorNotes T25	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T26	ANAT 891 905	tejido tumoral
T27	DISO 940 951	metastásico
#20	AnnotatorNotes T27	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T28	ANAT 1037 1047	cerebrales
#21	AnnotatorNotes T28	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T29	ANAT 1069 1083	leptomeníngeas
#22	AnnotatorNotes T29	C0228126; Leptomeninges; Body Part, Organ, or Organ Component | C1284563; Entire leptomeninges; Body Part, Organ, or Organ Component
T30	ANAT 1094 1100	ocular
#23	AnnotatorNotes T30	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T31	CHEM 60 70	Relatlimab
#24	AnnotatorNotes T31	C4724799; Relatlimab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T32	CHEM 276 286	Relatlimab
#25	AnnotatorNotes T32	C4724799; Relatlimab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T33	CHEM 288 298	BMS-986016
#26	AnnotatorNotes T33	C3827149; BMS-986016; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T34	Date 13 17	2017
T35	LIVB 132 141	pacientes
#27	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	Neg_cue 182 184	no
T37	LIVB 361 370	pacientes
#28	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	Neg_cue 411 413	no
T39	Neg_cue 540 542	no
T41	Neg_cue 768 770	no
T42	Spec_cue 1162 1172	sospechada
T40	PROC 724 747	estadificación del AJCC
#29	AnnotatorNotes T40	C1971458; American Joint Committee on Cancer (AJCC) stage documented and reviewed (ONC); Health Care Activity
T43	LIVB 1103 1116	Participantes
#30	AnnotatorNotes T43	C4554048; Study Participant; Population Group
T44	LIVB 595 608	participantes
#31	AnnotatorNotes T44	C4554048; Study Participant; Population Group
T45	LIVB 754 767	participantes
#32	AnnotatorNotes T45	C4554048; Study Participant; Population Group
T46	PROC 641 657	histológicamente
#33	AnnotatorNotes T46	C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T1 Negated
A2	Assertion T13 Negated
A3	Assertion T23 Negated
A4	Assertion T14 Negated
A5	Assertion T22 Speculated
A6	Status T1 History_of
A7	Status T13 History_of
A8	Status T23 History_of
A9	Status T14 History_of
A10	Status T22 History_of
#34	AnnotatorNotes T10	C0278883; Metastatic melanoma; Neoplastic Process 
#35	AnnotatorNotes T12	C0278883; Metastatic melanoma; Neoplastic Process 
#36	AnnotatorNotes T18	C1879847; Biomarker Analysis; Laboratory Procedure
#37	AnnotatorNotes T6	C1519042; Phase II/III Trial; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
R1	Combined_with Arg1:T31 Arg2:T2	
R2	Used_for Arg1:T3 Arg2:T4	
R3	Experiences Arg1:T35 Arg2:T31	
R4	Experiences Arg1:T35 Arg2:T3	
R5	Experiences Arg1:T35 Arg2:T5	
R6	Negation Arg1:T36 Arg2:T1	
#38	AnnotatorNotes T5	C0278883; Metastatic melanoma; Neoplastic Process
T47	Observation 169 181	irresectable
#39	AnnotatorNotes T47	C4039777; Tumor surgically unresectable; Finding
R7	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T47	
T48	Observation 398 410	irresectable
#40	AnnotatorNotes T48	C4039777; Tumor surgically unresectable; Finding
T49	Observation 527 539	irresectable
#41	AnnotatorNotes T49	C4039777; Tumor surgically unresectable; Finding
T50	Observation 926 937	irresecable
#42	AnnotatorNotes T50	C4039777; Tumor surgically unresectable; Finding
T51	Observation 674 685	irresecable
#43	AnnotatorNotes T51	C4039777; Tumor surgically unresectable; Finding
T52	Observation 846 857	irresecable
#44	AnnotatorNotes T52	C4039777; Tumor surgically unresectable; Finding
R10	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T52	
R11	Before Arg1:T15 Arg2:T25	
R12	Negation Arg1:T41 Arg2:T14	
R13	Experiences Arg1:T45 Arg2:T14	
R14	Experiences Arg1:T45 Arg2:T15	
R15	Experiences Arg1:T45 Arg2:T25	
R16	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T52	
R18	Experiences Arg1:T35 Arg2:T1	
R19	Combined_with Arg1:T32 Arg2:T7	
R20	Combined_with Arg1:T33 Arg2:T7	
R21	Used_for Arg1:T8 Arg2:T9	
R22	Experiences Arg1:T37 Arg2:T32	
R23	Experiences Arg1:T37 Arg2:T33	
R24	Experiences Arg1:T37 Arg2:T8	
R25	Experiences Arg1:T37 Arg2:T10	
R27	Negation Arg1:T38 Arg2:T13	
R28	Experiences Arg1:T37 Arg2:T13	
T53	Quantifier_or_Qualifier 469 477	avanzado
#45	AnnotatorNotes T53	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R29	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T53	
R30	Negation Arg1:T39 Arg2:T23	
#46	AnnotatorNotes T26	C0475358; Tumor tissue sample; Tissue
R32	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T50	
R33	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T50	
R34	Before Arg1:T17 Arg2:T27	
R35	Before Arg1:T16 Arg2:T27	
R36	Location_of Arg1:T26 Arg2:T17	
R37	Used_for Arg1:T26 Arg2:T18	
R40	Location_of Arg1:T28 Arg2:T19	
R41	Location_of Arg1:T29 Arg2:T20	
T54	Quantifier_or_Qualifier 1048 1055	activas
#47	AnnotatorNotes T54	C0679217; Active State; Idea or Concept
R42	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T54	
R43	Location_of Arg1:T30 Arg2:T21	
R44	Experiences Arg1:T43 Arg2:T22	
T55	Quantifier_or_Qualifier 1143 1149	activa
#48	AnnotatorNotes T55	C0679217; Active State; Idea or Concept
R45	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T55	
R46	Speculation Arg1:T42 Arg2:T22	
R48	Experiences Arg1:T44 Arg2:T24	
R49	Experiences Arg1:T44 Arg2:T46	
T56	Result_or_Value 661 672	estadio III
T57	Result_or_Value 692 702	estadio IV
R53	Has_Result_or_Value Arg1:T40 Arg2:T57	
R54	Has_Result_or_Value Arg1:T40 Arg2:T56	
R52	Experiences Arg1:T44 Arg2:T40	
R51	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T51	
A11	Experiencer T43 Patient
A12	Experiencer T35 Patient
A13	Experiencer T37 Patient
A14	Experiencer T44 Patient
A15	Experiencer T45 Patient
